Scott Delach

857 total citations
11 papers, 492 citations indexed

About

Scott Delach is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Scott Delach has authored 11 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Scott Delach's work include Cancer-related Molecular Pathways (4 papers), Advanced Breast Cancer Therapies (3 papers) and Cell death mechanisms and regulation (3 papers). Scott Delach is often cited by papers focused on Cancer-related Molecular Pathways (4 papers), Advanced Breast Cancer Therapies (3 papers) and Cell death mechanisms and regulation (3 papers). Scott Delach collaborates with scholars based in United States and Switzerland. Scott Delach's co-authors include Daniel E. Johnson, Andrew Worlock, Martha Rook, Richard S. Maser, Sanjeev Shangary, Lori A. Emert‐Sedlak, Q. Ping Dou, Cheryl L. Fattman, Giordano Caponigro and Brian Gastman and has published in prestigious journals such as Cancer Research, Oncogene and Clinical Cancer Research.

In The Last Decade

Scott Delach

11 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Scott Delach United States	8	340	126	85	84	66	11	492
Ginevra Caratù Spain	10	285 0.8×	187 1.5×	125 1.5×	77 0.9×	74 1.1×	17	484
Leenus Martin United States	9	378 1.1×	86 0.7×	69 0.8×	55 0.7×	33 0.5×	11	476
A. Mazo Spain	10	247 0.7×	242 1.9×	86 1.0×	76 0.9×	69 1.0×	19	577
Sarah Sabir United Kingdom	6	354 1.0×	163 1.3×	76 0.9×	124 1.5×	61 0.9×	6	540
Naoe Taira Japan	11	544 1.6×	297 2.4×	127 1.5×	45 0.5×	47 0.7×	13	737
Sean F. Landrette United States	12	441 1.3×	108 0.9×	61 0.7×	26 0.3×	83 1.3×	18	663
Elettra Bianchi Belgium	12	248 0.7×	141 1.1×	87 1.0×	42 0.5×	33 0.5×	28	497
M. V. Viola United States	13	303 0.9×	193 1.5×	85 1.0×	60 0.7×	67 1.0×	21	608
Corrado Caslini United States	14	746 2.2×	139 1.1×	99 1.2×	26 0.3×	46 0.7×	20	937
Christopher S. Bland United States	5	578 1.7×	105 0.8×	93 1.1×	26 0.3×	67 1.0×	5	728

Countries citing papers authored by Scott Delach

Since Specialization

Citations

This map shows the geographic impact of Scott Delach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Delach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Delach more than expected).

Fields of papers citing papers by Scott Delach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Delach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Delach. The network helps show where Scott Delach may publish in the future.

Co-authorship network of co-authors of Scott Delach

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Delach. A scholar is included among the top collaborators of Scott Delach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Delach. Scott Delach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Delach, Scott & Giordano Caponigro. (2021). Abstract PS19-10: Preclinical head-to-head comparison of CDK4/6 inhibitor activity toward CDK4 vs CDK6. Cancer Research. 81(4_Supplement). PS19–10. 2 indexed citations

Delach, Scott, Paul Fordjour, Yun Feng, et al.. (2019). Abstract LB-114: RAF inhibitor LXH254 effectively inhibits B-and-CRAF, but not ARAF. Cancer Research. 79(13_Supplement). LB–114. 2 indexed citations

Kim, Sunkyu, Ralph Tiedt, Alice Loo, et al.. (2018). The potent and selective cyclin-dependent kinases 4 and 6 inhibitor ribociclib (LEE011) is a versatile combination partner in preclinical cancer models. Oncotarget. 9(81). 35226–35240. 58 indexed citations

Tiedt, Ralph, Scott Delach, Thomas Horn, et al.. (2017). Abstract 2346: Preclinical selectivity profile of the CDK4/6 inhibitor ribociclib (LEE011) compared with that of palbociclib and abemaciclib. Cancer Research. 77(13_Supplement). 2346–2346. 1 indexed citations

Linehan, W. Marston, Ping Wang, Marissa N. Balak, et al.. (2017). BRAF-inhibitor Associated MEK Mutations Increase RAF-Dependent and -Independent Enzymatic Activity. Molecular Cancer Research. 15(10). 1431–1444. 18 indexed citations

Hart, Lori S., JulieAnn Rader, Pichai Raman, et al.. (2016). Preclinical Therapeutic Synergy of MEK1/2 and CDK4/6 Inhibition in Neuroblastoma. Clinical Cancer Research. 23(7). 1785–1796. 57 indexed citations

Emert‐Sedlak, Lori A., et al.. (2005). Involvement of cathepsin D in chemotherapy-induced cytochrome c release, caspase activation, and cell death. Molecular Cancer Therapeutics. 4(5). 733–742. 84 indexed citations

Rook, Martha, et al.. (2004). Whole Genome Amplification of DNA from Laser Capture-Microdissected Tissue for High-Throughput Single Nucleotide Polymorphism and Short Tandem Repeat Genotyping. American Journal Of Pathology. 164(1). 23–33. 86 indexed citations

Fattman, Cheryl L., Scott Delach, Q. Ping Dou, & Daniel E. Johnson. (2001). Sequential two-step cleavage of the retinoblastoma protein by caspase-3/-7 during etoposide-induced apoptosis. Oncogene. 20(23). 2918–2926. 46 indexed citations

10.

Maser, Richard S., et al.. (2001). Isolation of Bcl-2 Binding Proteins That Exhibit Homology with BAG-1 and Suppressor of Death Domains Protein. Biochemical and Biophysical Research Communications. 286(5). 1003–1010. 80 indexed citations

11.

Gastman, Brian, Eva Wieckowski, Guoqing Wang, et al.. (2000). Inhibitor of apoptosis protein hILP undergoes caspase-mediated cleavage during T lymphocyte apoptosis.. PubMed. 60(7). 1818–23. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact